Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Liver International : Official Journal of the International Association for the Study of the Liver|June 26, 2026
From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD ManagementMonica Radu, Margarita Papatheodoridi, Habiba Kamal Khodir, et al.
Hepatology Communications|May 16, 2025
Dynamics of HBV biomarkers during nucleos(t)ide analog treatment: A 14-year studyFlorian van Bömmel, Elisabetta Degasperi, Alena van Bömmel, et al.
Hepatology (Baltimore, Md.)|May 12, 2026
Diabetes, male sex, low levels of HBsAg, HDV RNA and ALT predict spontaneous HDV suppression in chronic hepatitis DHabiba Kamal, Ganbolor Jargalsaikhan, Sanjaasuren Enkhtaivan, et al.
JHEP Reports : Innovation in Hepatology|January 26, 2024
Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populationsLouis Shekhtman, Scott J Cotler, Elisabetta Degasperi, et al.
Gut|October 25, 2023
Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis BBarbara Testoni, Caroline Scholtès, Marie-Laure Plissonnier, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 4, 2026
ASAP score predicts early HCC recurrence after complete radiological response to locoregional treatmentsLorenzo Canova, Massimo Iavarone, Eleonora Alimenti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 30, 2019
Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver diseaseGiulia Tosetti, Massimo Primignani, Vincenzo La Mura, et al.
Alimentary Pharmacology & Therapeutics|November 5, 2021
Prothrombin induced by vitamin K absence or antagonist-II and alpha foetoprotein to predict development of hepatocellular carcinoma in Caucasian patients with hepatitis C-related cirrhosis treated with direct-acting antiviral agentsElisabetta Degasperi, Riccardo Perbellini, Roberta D'Ambrosio, et al.
JHEP Reports : Innovation in Hepatology|February 15, 2024
Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failureChristiana Graf, Roberta D'Ambrosio, Elisabetta Degasperi, et al.
Alimentary Pharmacology & Therapeutics|March 29, 2023
Long-term endoscopic surveillance in HBV compensated cirrhotic patients treated with Tenofovir or Entecavir for 11 yearsElisa Farina, Alessandro Loglio, Giulia Tosetti, et al.
Pageof 9